Sort
141,003 grants matching “cytokine”
Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment
$1,000,000Robert F Place · Mirecule, Inc. · U44 · FY2020 · CA
Programming Metabolically Fit TILs for Immunotherapy
$1,000,000Shikhar Mehrotra · Lipo-Immuno Tech, Llc · R42 · FY2023 · CA
Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation
$1,000,000George Norbert Cox · Bolder Biotechnology, Inc. · R44 · FY2023 · AI
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2019 · DK
Preclinical development of an immunomodulatory agent capable of mitigating SARS-CoV-2 virus related hypercytokinemia
$1,000,000Jodi K Craigo · Cytoagents, Inc. · R44 · FY2022 · AI
Vaccine Strategies for Candidal Infections
$1,000,000John P Hennessey · Novadigm Therapeutics, Inc. · R42 · FY2010 · AI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure
$1,000,000Barbara Maria Olszewska-Pazdrak · Chrysalis Biotherapeutics, Inc. · R44 · FY2012 · AI
GASTROINTESTINAL HORMONE RESEARCH CORE CENTER
$1,000,000University Of Michigan At Ann Arbor · P30 · FY2001 · DK
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
$1,000,000Neil A Fanger · Virtici, Llc · R44 · FY2017 · AI
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · SB1 · FY2025 · AI
A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis
$1,000,000Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · AI
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
$1,000,000Paul Joseph Utz · Stanford University · R01 · FY2019 · AI
SIRPant Technology for anti-Cancer Immunity
$1,000,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2023 · CA
Programming Metabolically Fit TILs for Immunotherapy
$1,000,000Shikhar Mehrotra · Lipo-Immuno Tech, Llc · R42 · FY2024 · CA
Mitigation of Radiation-Induced Lung Injury in the Dog Model
$1,000,000David K Madtes · Fred Hutchinson Cancer Research Center · RC1 · FY2008 · AI
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2018 · DK
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2018 · CA
An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC
$1,000,000Jennifer A Schwartz · Profectus Biosciences, Inc. · R44 · FY2016 · AI
GASTROINTESTINAL HORMONE RESEARCH CORE CENTER
$1,000,000University Of Michigan At Ann Arbor · P30 · FY2003 · DK
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis
$1,000,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2021 · HL
Bifunctional T cell receptor based immunotherapeutics
$1,000,000Hing C. Wong · Altor Bioscience. Llc · R44 · FY2009 · CA
Integrated Microfluidic System for Oral Diagnostics
$1,000,000Sandia Corp-Sandia National Laboratories · U01 · FY2002 · DE
Preclinical development of an immunomodulatory agent capable of mitigating SARS-CoV-2 virus related hypercytokinemia
$1,000,000Jodi K Craigo · Cytoagents, Inc. · R44 · FY2021 · AI
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
$1,000,000Paul Joseph Utz · Stanford University · R01 · FY2016 · AI
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · R44 · FY2021 · AI